Inactive Instrument

Company Interpace Biosciences, Inc. Other OTC

Equities

IDXG

US46062X3035

Managed Healthcare

Business Summary

Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. The Company, through its Interpace Diagnostics, provides clinically useful molecular diagnostic tests and bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology. It has five commercialized molecular tests and one test in a clinical evaluation program: PancraGEN, which is for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts; PanDNA, which is a molecular version of PancraGEN that provides physicians a snapshot of a limited number of factors; ThyGeNEXT, which is for the diagnosis of thyroid cancer from thyroid nodules utilizing a sequencing assay; ThyraMIR v2, used in combination with ThyGeNEXT, for the diagnosis of thyroid cancer, and RespriDX, which differentiates lung cancer of primary versus metastatic origin.

Sales per Business

USD in Million2021Weight2022Weight Delta
Diagnostic Clinical Services
100.0 %
41 100.0 % 32 100.0 % -22.94%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
41 100.0 % 32 100.0 % -22.94%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 20-11-30
Director of Finance/CFO 32 19-05-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal - -
Human Resources Officer - 21-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 75 22-01-31
Director/Board Member 71 15-12-31
Director/Board Member 77 04-08-31
Director/Board Member 62 20-01-21
Chief Executive Officer 62 20-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 47,000 0 0 72.25 %
Stock B 1 4,407,492 3,184,448 ( 72.25 %) 85,720 ( 1.945 %)

Shareholders

NameEquities%Valuation
781,956 18.09 % 821 054 $
250,000 5.785 % 262 500 $
56,521 1.308 % 59 347 $
45,644 1.056 % 47 926 $
18,759 0.4341 % 19 697 $
2,459 0.0569 % 2 582 $
1,757 0.0407 % 1 845 $
SciVest Alternative Strategies, Inc.
0.003748 %
162 0.003748 % 170 $
NWD Investments
0.001851 %
80 0.001851 % 84 $
Merrill Lynch Investment Managers, Inc.
0.000787 %
34 0.000787 % 36 $
NameEquities%Valuation
Ampersand Management LLC
59.57 %
28,000 59.57 % 29 400 $
1315 Capital LLC
40.43 %
19,000 40.43 % 19 950 $

Company contact information

Interpace Biosciences, Inc.

Waterview Plaza Suite 310

07054, Parsippany

+855 776 6419

http://www.interpacediagnostics.com
address Interpace Biosciences, Inc.(IDXG)